Nevro Cash on Hand 2013-2024 | NVRO

Nevro cash on hand from 2013 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Nevro Annual Cash on Hand
(Millions of US $)
2023 $323
2022 $374
2021 $362
2020 $588
2019 $238
2018 $265
2017 $269
2016 $276
2015 $194
2014 $177
2013 $57
2012 $31
Nevro Quarterly Cash on Hand
(Millions of US $)
2024-03-31 $281
2023-12-31 $323
2023-09-30 $320
2023-06-30 $330
2023-03-31 $342
2022-12-31 $374
2022-09-30 $387
2022-06-30 $311
2022-03-31 $324
2021-12-31 $362
2021-09-30 $377
2021-06-30 $398
2021-03-31 $576
2020-12-31 $588
2020-09-30 $573
2020-06-30 $562
2020-03-31 $248
2019-12-31 $238
2019-09-30 $233
2019-06-30 $234
2019-03-31 $240
2018-12-31 $265
2018-09-30 $258
2018-06-30 $264
2018-03-31 $260
2017-12-31 $269
2017-09-30 $271
2017-06-30 $263
2017-03-31 $264
2016-12-31 $276
2016-09-30 $288
2016-06-30 $290
2016-03-31 $163
2015-12-31 $194
2015-09-30 $223
2015-06-30 $254
2015-03-31 $159
2014-12-31 $177
2014-09-30 $34
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2012-12-31 $31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.349B $0.425B
Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $208.577B 25.27
Intuitive Surgical (ISRG) United States $163.861B 92.78
Edwards Lifesciences (EW) United States $53.023B 34.51
Alcon (ALC) Switzerland $44.787B 32.08
IQVIA Holdings (IQV) United States $44.681B 25.33
DexCom (DXCM) United States $44.401B 67.26
IDEXX Laboratories (IDXX) United States $39.253B 46.01
STERIS (STE) Ireland $22.615B 26.42
Hologic (HOLX) United States $18.292B 20.47
Waters (WAT) United States $18.224B 26.78
SONOVA HOLDING (SONVY) Switzerland $17.878B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $11.502B 13.43
Teleflex (TFX) United States $10.485B 16.32
Sysmex ADR (SSMXY) Japan $10.241B 32.12
Globus Medical (GMED) United States $9.940B 29.14
Penumbra (PEN) United States $7.453B 84.69
Glaukos (GKOS) United States $6.184B 0.00
Masimo (MASI) United States $5.714B 32.86
TransMedics (TMDX) United States $4.913B 466.16
Integer Holdings (ITGR) United States $4.328B 26.15
PROCEPT BioRobotics (PRCT) United States $3.553B 0.00
Inari Medical (NARI) United States $3.210B 0.00
LivaNova (LIVN) United Kingdom $2.938B 17.45
Tandem Diabetes Care (TNDM) United States $2.792B 0.00
Integra LifeSciences Holdings (IART) United States $2.485B 10.84
Veracyte (VCYT) United States $1.794B 0.00
RxSight (RXST) United States $1.754B 0.00
Alphatec Holdings (ATEC) United States $1.525B 0.00
Artivion (AORT) United States $1.146B 109.88
Silk Road Medical (SILK) United States $1.067B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.033B 20.10
Pulse Biosciences (PLSE) United States $1.030B 0.00
OPKO Health (OPK) United States $1.018B 0.00
OrthoPediatrics (KIDS) United States $0.789B 0.00
SiBone (SIBN) United States $0.693B 0.00
Paragon 28 (FNA) United States $0.672B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.602B 0.00
Mesa Laboratories (MLAB) United States $0.599B 17.73
IRadimed (IRMD) United States $0.584B 32.68
Treace Medical Concepts (TMCI) United States $0.493B 0.00
Pacific Biosciences Of California (PACB) United States $0.490B 0.00
AxoGen (AXGN) United States $0.404B 0.00
Sight Sciences (SGHT) United States $0.397B 0.00
Tactile Systems Technology (TCMD) United States $0.301B 10.31
AngioDynamics (ANGO) United States $0.286B 0.00
Semler Scientific (SMLR) United States $0.242B 12.28
Delcath Systems (DCTH) United States $0.231B 0.00
NeuroPace (NPCE) United States $0.220B 0.00
Inogen (INGN) United States $0.217B 0.00
CVRx (CVRX) United States $0.212B 0.00
ClearPoint Neuro (CLPT) United States $0.198B 0.00
Accuray (ARAY) United States $0.194B 0.00
908 Devices (MASS) United States $0.191B 0.00
Atossa Genetics (ATOS) United States $0.186B 0.00
EDAP TMS S.A (EDAP) France $0.184B 0.00
Alpha Tau Medical (DRTS) Israel $0.144B 0.00
KORU Medical Systems (KRMD) United States $0.120B 0.00
Spectral Diagnostics (EDTXF) Canada $0.106B 0.00
Sensus Healthcare (SRTS) United States $0.106B 22.24
Hyperfine (HYPR) United States $0.085B 0.00
EnVVeno Medical (NVNO) United States $0.076B 0.00
Monogram Orthopaedics (MGRM) United States $0.072B 0.00
LENSAR (LNSR) United States $0.060B 0.00
InspireMD (NSPR) Israel $0.060B 0.00
Neuronetics (STIM) United States $0.057B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Vicarious Surgical (RBOT) United States $0.044B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.036B 0.00
ReWalk Robotics (LFWD) Israel $0.033B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
Rapid Micro Biosystems (RPID) United States $0.030B 0.00
Autonomix Medical (AMIX) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.026B 0.00
Ekso Bionics Holdings (EKSO) United States $0.023B 0.00
Aspira Women's Health (AWH) United States $0.022B 0.00
Pixie Dust Technologies (PXDT) Japan $0.021B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
NexGel (NXGL) United States $0.015B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00